Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations

Yoo WS, Kim DH, Kim HJ, Chung HK

BACKGROUND: Insulin therapy is the treatment of choice in type 2 diabetes mellitus (T2DM) patients who are not achieving glycemic goals despite triple oral hypoglycemic agent (OHA) combination therapy. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Mentors, The Social Support and Patients with Diabetes Mellitus

Park YJ

In countries with advanced health practices, it is important to note the importance of social capital and social support as social determinants in patient health as early as possible, while...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intake of Fruits for Diabetics: Why and How Much?

Lee EY

Fruits are universally promoted as healthy. Fruits supply dietary fiber, vitamins, minerals and phytochemicals that function as antioxidants. But many people often have concerns that fruit intake has a negative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Education of Patients with Diabetes Mellitus and Peripheral Artery Disease

Yun HR

Peripheral artery disease (PAD) and diabetes increase the risk of significant morbidity and mortality and can affect quality of life. PAD is a progressive disease, and the presence of diabetes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sodium-Glucose Cotransporter 2 Inhibitors for People with Type 1 Diabetes

Kim CH, Moon JS

Althowgh intensive insulin regimen is the main treatment in people with type 1 diabetes, glucose variability and weight gain remain as challenges for this treatment. Sodium-glucose cotransporter (SGLT) inhibitors (including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of Major Adverse Cardiovascular and Renal Outcomes with Sodium-Glucose Cotransporter 2 Inhibitors

Hong JH

Management of hyperglycemia limits progression of microvascular complications in type 2 diabetes mellitus (T2DM). According to large-scale randomized control studies to demonstrate the cardiovascular safety of sodium-glucose cotransporter 2 (SGLT2)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Potential Cardioprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors

Jeon JH

The potential mechanism by which sodium-glucose cotransporter 2 (SGLT2) inhibitors prevent cardiovascular disease (CVD) is being widely investigated. Improved insulin resistance, along with decreased body fat mass associated with SGLT2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sodium-Glucose Cotransporter 2 Inhibitors: Mechanisms of Action and Various Effects

Kim KS

The basic action mechanism of sodium-glucose cotransporter 2 (SGLT2) inhibitor is to lower the glucose burden by excreting the glucose filtered by the kidney into the urine. Although SGLT2 inhibitors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Connections between Diabetes and Cognitive Dysfunction

Lee SH

Dementia, a clinical syndrome affecting memory, thinking, and social abilities primarily caused by neurodegeneration, is becoming one of the greatest health and socioeconomic burdens in the aging society. The age-standardized...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Saxenda® Frenzy: Opinions of an Endocrine and Metabolism Specialist

Kim S

Globally, the problem of obesity is increasing, and the prevalence of obesity in Korea is also rising rapidly. Obesity is a risk factor for cardiometabolic diseases including type 2 diabetes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr